GlassScriptPhysician profile
Michael R Sanchez
NPI 1164494704
$545.06
in general payments reported to CMS, 2019-2025
6 companies · $136 in 2025
The $136 reported for 2025 was more than what 81% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.41 · 2023: $175 · 2024: $140 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432 · Education: $18.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.49 |
| Education | $18.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $233.08 | 2022-2025 | Stelara, Tremfya |
| Boston Scientific Corporation | $105.84 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Abbott Laboratories | $96.00 | 2023-2024 | Perclose Proglide, Perclose Prostyle, Supera |
| Takeda Pharmaceuticals U.S.A., INC. | $72.51 | 2023-2025 | Entyvio, Gattex |
| Qol Medical, LLC | $19.47 | 2025 | Sucraid |
| Celltrion USA INC. | $18.16 | 2024 | Zymfentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.